Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With High-Risk Multiple Myeloma
Clinical trial NCT03756896 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03756896
- Sponsor
- Emory University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-25
- Primary completion
- 2025-06-24
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.